<DOC>
	<DOCNO>NCT02008448</DOCNO>
	<brief_summary>The investigator conduct prospective , double-blind , randomize study ass comparative safety efficacy two different ablation strategy , PVI plus linear lesion ( LL ) plus botulinum toxin injection versus PVI plus linear lesion ( LL ) , patient persistent longstanding persistent AF . Results assess use implanted monitoring device ( IMD ) .</brief_summary>
	<brief_title>Endomyocardial Botulinum Toxin Injection Patients With Persistent Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Persistent longstanding persistent AF congestive heart failure LV ejection fraction &lt; 35 % leave atrial diameter &gt; 60 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>